Letter to the EditorGlecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings
Keywords
hepatitis C virus
direct-acting antivirals
retreatment
salvage therapy
glecaprevir/pibrentasvir
sofosbuvir
ribavirin
Cited by (0)
© 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.